Literature DB >> 15849825

Influential factors and formation of extrahepatic collateral artery in unresectable hepatocellular carcinoma.

Yong-Li Wang1, Ming-Hua Li, Ying-Sheng Cheng, Hai-Bing Shi, Hai-Lun Fan.   

Abstract

AIM: To analyze the influence factors and formation of extrahepatic collateral arteries (ECAs) in unresectable hepatocellular carcinoma (HCC) with or without chemoembolization.
METHODS: Detailed histories of 35 patients with 39 ECAs of HCC and images including computerized tomography scan, digital subtraction angiography were reviewed carefully to identify ECAs of HCC, ECAs arising from, and anatomic location of tumors in liver. Tumor sizes were measured, and relations of ECAs with times of chemoembolization, tumor size, and the anatomic tumor location were analyzed. Complications were observed after chemoembolization through ECAs of HCC with different techniques.
RESULTS: Influence factors of formation of ECAs of HCC included the times of repeated chemoembolization, the location of tumors in liver, the tumor size and the types of chemoembolization. ECAs in HCC appeared after 3-4 times of chemoembolization (17.9%), but a higher frequency of ECAs occurred after 5-6 times of chemoembolization (56.4%). ECAs presented easily in peripheral areas (71.8%) of liver abutting to the anterior, posterior abdominal walls, the top right of diaphragm and right kidney. ECAs also occurred easily after complete obstruction of the trunk arteries supplying HCCs or the branches of proper hepatic arteries. Extrahepatic collaterals of HCC originated from right internal thoracic (mammary) artery (RITA, 5.1%), right intercostal artery (RICA, 7.7%), left gastric artery (LGA, 12.8%), right inferior phrenic artery (RIPA, 38.5%), omental artery (OTA, 2.6%), superior mesenteric artery (SMA, 23.1%), and right adrenal and renal capsule artery (RARCA, 10.3%), respectively. The complications after chemoembolization attributed to no super selective catheterization.
CONCLUSION: The formation of ECAs in unresectable HCC is obviously correlated with multiple chemoembolization, tumor size, types of chemoembolization, anatomic location of tumors. Extrahepatic collaterals in HCC are corresponding to the tumor locations in liver.

Entities:  

Mesh:

Year:  2005        PMID: 15849825      PMCID: PMC4305757          DOI: 10.3748/wjg.v11.i17.2637

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

Review 1.  Chemoembolization of hepatic neoplasms: safety, complications, and when to worry.

Authors:  J Gates; G G Hartnell; K E Stuart; M E Clouse
Journal:  Radiographics       Date:  1999 Mar-Apr       Impact factor: 5.333

2.  Hepatocellular carcinoma: involvement of the internal mammary artery.

Authors:  M Nakai; M Sato; N Kawai; H Minamiguchi; M Masuda; H Tanihata; T Takeuchi; M Terada; K Kishi
Journal:  Radiology       Date:  2001-04       Impact factor: 11.105

3.  Effect of preoperative transcatheter arterial chemoembolization on apoptosis of hepatocellular carcinoma cells.

Authors:  Enhua Xiao; Detai Li; Shubin Shen; Shunke Zhou; Lihua Tan; Yunhua Wang; Jianguang Luo; Yuzhi Wu; Changlian Tan; Hui Liu; Hui Zhu
Journal:  Chin Med J (Engl)       Date:  2003-02       Impact factor: 2.628

4.  Transcatheter arterial embolization of internal mammary artery in a hepatocellular carcinoma with abdominal wall invasion.

Authors:  A Memis; I Oran; C Calli; Y Yuzer; A Mentes
Journal:  Eur J Radiol       Date:  1998-09       Impact factor: 3.528

5.  Abdominal wall necrosis following transcatheter arterial chemoembolization for hepatocellular carcinoma.

Authors:  H J Liu; T S Chen; R C Lee; D M Ho; J T Lin; L S Chu; F Y Chang
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  2000-11

6.  Extrahepatic collateral supply of hepatocellular carcinoma by the intercostal arteries.

Authors:  Sung Il Park; Do Yun Lee; Jong Yoon Won; Jong Tae Lee
Journal:  J Vasc Interv Radiol       Date:  2003-04       Impact factor: 3.464

7.  Cardiac tamponade caused by spontaneous rupture of mediastinal lymph node metastasis of hepatocellular carcinoma.

Authors:  S Seki; T Kitada; H Sakaguchi; K Nakatani; T Kamino; K Nakamura; R Yamada
Journal:  J Gastroenterol Hepatol       Date:  2001-06       Impact factor: 4.029

Review 8.  Multimodal treatment of hepatocellular carcinoma (HCC).

Authors:  J W Sturm; M Keese
Journal:  Onkologie       Date:  2004-06

9.  Outcome of transcatheter oily chemoembolization in patients with hepatocellular carcinoma.

Authors:  Charindr Eurvilaichit
Journal:  Hepatogastroenterology       Date:  2004 Jan-Feb

10.  Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.

Authors:  Man Fung Yuen; Annie On-On Chan; Benjamin Chun-Yu Wong; Chee Kin Hui; Gaik Cheng Ooi; Wai Kuen Tso; He Jun Yuan; Danny Ka-Ho Wong; Ching Lung Lai
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

View more
  8 in total

1.  Superior phrenic artery: an anatomic study.

Authors:  Marios Loukas; Robert G Louis; Christopher T Wartmann; R Shane Tubbs; Ehsan Esmaeili; Allyson C Bagenholm; William Merbs; Brian Curry; Robert Jordan
Journal:  Surg Radiol Anat       Date:  2006-12-20       Impact factor: 1.246

2.  Hepatocellular carcinoma with blood supply from parasitized omental artery: angiographic appearance and chemoembolization.

Authors:  Song Gao; Ren-Jie Yang; Jia-Hong Dong
Journal:  Chin J Cancer Res       Date:  2012-09       Impact factor: 5.087

3.  Angiographic evaluation of hepatic arterial injury after cisplatin and Gelfoam-based transcatheter arterial chemoembolization for hepatocellular carcinoma in a 205 patient cohort during a 6-year follow-up.

Authors:  C H Suh; J H Shin; H M Yoon; H-K Yoon; G-Y Ko; D-I Gwon; J-H Kim; K-B Sung
Journal:  Br J Radiol       Date:  2014-06-27       Impact factor: 3.039

4.  Evaluation of extrahepatic collateral arteries in hepatocellular carcinoma in three independent groups in a single center.

Authors:  Yilin Zhao; Zhuting Fang; Jianjun Luo; Qingxin Liu; Gang Xu; Heng Pan; Wei Wei; Zhiping Yan
Journal:  Exp Ther Med       Date:  2015-10-22       Impact factor: 2.447

5.  Hepatocellular carcinomas smaller than 4 cm supplied by the intercostal artery: can we predict which intercostal artery supplies the tumor?

Authors:  Saebeom Hur; Hyo-Cheol Kim; Jin Wook Chung; Min-Uk Kim; Ji Dae Kim; Gyoung Min Kim; In Joon Lee; Young Il Kim; Hwan Jun Jae; Jae Hyung Park
Journal:  Korean J Radiol       Date:  2011-09-27       Impact factor: 3.500

6.  Predictive factors for the benefit of triple-drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma.

Authors:  MinKe He; Qing Li; JingXian Shen; GuoSheng Tan; QiJiong Li; JiaYing Lai; Wei Wei; YaoJun Zhang; RuHai Zou; MinShan Chen; RongPing Guo; Ming Shi
Journal:  Cancer Med       Date:  2019-06-17       Impact factor: 4.452

7.  Extrahepatic Vascular Parasitization by a Hepatocellular Carcinoma.

Authors:  Marco Ertreo; Daniel R Swerdlow; Alexander Kim; Alexander S Somwaru
Journal:  Cureus       Date:  2019-09-30

8.  Ectopic blood supply of hepatocellular carcinoma as depicted by angiography with computed tomography: associations with morphological features and therapeutic history.

Authors:  Guang-Wen Chen; Bin Song; Zhen-Lin Li; Yuan Yuan
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.